Watertown, MA, United States of America

Solymar Negretti

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Foghorn Therapeutics Inc.. Active years: 2024-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Solymar Negretti: Innovator in BAF Complex-Related Disorders

Introduction

Solymar Negretti is a prominent inventor based in Watertown, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of BAF complex-related disorders. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Negretti's latest patents include "Compounds and uses thereof," which features compounds useful for the treatment of BAF complex-related disorders. This patent discloses compounds of Formula I, or pharmaceutically acceptable salts thereof, and formulations containing the same. Additionally, methods of treating BAF complex-related disorders, such as cancer, are also disclosed in her work.

Career Highlights

Solymar Negretti is currently employed at Foghorn Therapeutics Inc., where she continues to advance her research and development efforts. Her expertise in the field has positioned her as a key player in the pharmaceutical industry.

Collaborations

Negretti collaborates with notable colleagues, including Shawn E R Schiller and Kevin J Wilson, to further enhance the impact of her research.

Conclusion

In summary, Solymar Negretti is an influential inventor whose work in BAF complex-related disorders is making a significant impact in the pharmaceutical field. Her innovative patents and collaborations are contributing to the advancement of medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…